Amlitelimab Phase 2b data show potential best-in-class profile in atopic dermatitis: Sanofi Ruchika Sharma16 Oct 2023 1:30 PM ISTParis: Sanofi has announced positive results from a Phase 2b study (STREAM-AD). The results showed that amlitelimab significantly improved signs...
Sanofi-Teva Pharma to co-develop, co-commercialize inflammatory bowel disease treatment Ruchika Sharma5 Oct 2023 2:30 PM ISTParis: Sanofi and Teva Pharmaceuticals, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. have announced a collaboration to co-develop and...
Sanofi, Janssen ink pact to develop vaccine for extraintestinal pathogenic E. coli Ruchika Sharma4 Oct 2023 5:30 PM ISTSanofi will pay USD 175M upfront to Janssen, followed by development and commercial milestones.
Sanofi Dupixent sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for USFDA priority review Ruchika Sharma28 Sept 2023 2:30 PM ISTParis: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License...
Sanofi once-weekly Altuviiio approved in Japan for hemophilia A Ruchika Sharma25 Sept 2023 5:01 PM ISTParis: Sanofi has announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for ALTUVIIIO...
Sanofi India declares 12 percent growth in operating profits despite NLEM impact in Q2 Ruchika Sharma13 Aug 2023 10:00 AM ISTMumbai: Sanofi India Limited (SIL) has declared its financial results for the quarter and half year ended on June 30th, 2023. The Company has...
Sanofi India People Director Gaurav Bahadur resigns Ruchika Sharma5 Aug 2023 10:30 AM ISTMumbai: Sanofi India Limited has announced that Gaurav Bahadur, India People Director, has resigned from the Company with effect from the close...
Sanofi-AstraZeneca Beyfortus gets unanimous US CDC Advisory Committee recommendation to prevent RSV in neonates, infants Ruchika Sharma4 Aug 2023 1:09 PM ISTParis: Sanofi has recently announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization...
Sanofi to acquire Qunol Ruchika Sharma28 July 2023 1:30 PM ISTParis: Sanofi has announced it has entered into a definitive agreement to acquire ownership of Qunol, a U.S.-based brand in health & wellness....
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
Sanofi Dupixent gets nod in India for treatment of adults with moderate-to-severe atopic dermatitis Ruchika Sharma11 July 2023 1:12 PM ISTDupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.
Nirsevimab delivers 83 percent reduction in RSV infant hospitalizations in a real world clinical trial setting: Sanofi Ruchika Sharma14 May 2023 2:00 PM ISTRSV is the most common cause of LRTD, including bronchiolitis and pneumonia, in infants.
